Latest news

Dr Rafael Bernabeu addresses the uterine factor as a cause of recurrent pregnancy loss at SEGO

  • 12/11/19

Dr Rafael Bernabeu, Medical Director at Instituto Bernabeu, gave a speech within the framework of the ‘Review and updated handling of recurrent pregnancy loss’ course held in Madrid. The event was organised by the Spanish Society of Gynaecology and Obstetrics (SEGO).

Read more

Instituto Bernabeu investigates the factors that may affect successful embryo transfer

  • 12/10/19

A team of researchers from the Embryology and Reproductive Medicine Units at Instituto Bernabeu in Madrid and Alicante have completed a study of the factors that may have the greatest impact on embryo transfer rates following a cycle of assisted reproduction. The research work was presented at the Association for the Study of Reproduction Biology (ASEBIR) Congress held in late October in Cáceres.

Read more

An Instituto Bernabeu study analyses if ovarian stimulation can alter the risk of aneuploidies and mosaicism in embryos

  • 12/05/19

The aim of research work performed by the Genetics and Molecular Biology Department at Instituto Bernabeu IBBiotech was to determine if there is a relationship between the ovarian stimulation process in cycles of in vitro fertilisation (IVF) and the aneuploidy and mosaicism rate in embryos. The conclusions were presented at the Association for the Study of Reproduction Biology (ASEBIR) Congress held in October in Cáceres.

Read more

An Instituto Bernabeu research project demonstrates that the aneuploidy and mosaicism rates in blastocysts is similar in vitrified oocytes and fresh oocytes

  • 12/03/19

Instituto Bernabeu gave an oral communication about oocyte vitrification at the Association for the Study of Reproduction Biology (ASEBIR) Congress held in Cáceres in October. Freezing is common practice during in vitro fertilisation (IVF) treatment because it increases the available number of blastocysts for analysis.

Read more